Jushi Holdings (JUSHF) Invested Capital (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Invested Capital came in at $12.9 million in Q1 2026, up 234.9% year-on-year from $3.8 million in Q1 2025, and down 80.07% on a QoQ basis from $64.7 million in Q4 2025.
Jushi Holdings (JUSHF) Invested Capital (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Invested Capital data on file, last reported at $12.9 million in Q1 2026.
- On a quarterly basis, Invested Capital rose 234.9% year-over-year to $12.9 million in Q1 2026; TTM through Mar 2026 was $133.5 million, a 71.38% increase from a year earlier, with the FY2025 full-year figure at $64.7 million, up 3.75% from the prior year.
- Invested Capital for Q1 2026 stood at $12.9 million, down from $64.7 million in the prior quarter.
- Over the last five years, Invested Capital for JUSHF reached as high as $113.7 million in Q4 2022 and fell as low as -$45.8 million in Q2 2023.
- Historically, Invested Capital has averaged $49.6 million across 5 years, with a median of $61.5 million in 2023.
- Across the five-year window, Invested Capital slumped 143.11% in 2023 and soared 2644.86% in 2025, its largest moves.
- Year by year, Invested Capital stood at $113.7 million in 2022, then plunged by 45.73% to $61.7 million in 2023, then advanced by 0.99% to $62.3 million in 2024, then advanced by 3.75% to $64.7 million in 2025, then sank by 80.07% to $12.9 million in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $12.9 million in Q1 2026, $64.7 million in Q4 2025, and $48.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 12.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.89 Mn |
| Dec 31, 2025 | 64.67 Mn |
| Sep 30, 2025 | 48.89 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 62.34 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 9.95 Mn |
| Mar 31, 2024 | 61.40 Mn |
| Dec 31, 2023 | 61.72 Mn |
| Sep 30, 2023 | 61.64 Mn |
| Jun 30, 2023 | -45.77 Mn |
| Mar 31, 2023 | 112.50 Mn |
| Dec 31, 2022 | 113.74 Mn |
| Sep 30, 2022 | 110.82 Mn |
| Jun 30, 2022 | 106.16 Mn |
| Dec 31, 2021 | 6.18 Mn |